[TLX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -101.50%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 160,096 7,596 5,213 3,485 195 0 0 -
PBT -98,622 -99,039 -60,253 -42,815 -15,714 -6,377 -44 261.54%
Tax 5,457 -18,529 -15,366 -14,948 -1,884 9 -14 -
NP -104,079 -80,510 -44,887 -27,867 -13,830 -6,377 -44 264.80%
Tax Rate - - - - - - - -
Total Cost 264,175 88,106 50,100 31,352 14,025 6,377 44 326.04%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -65.01 -1,059.90 -861.06 -799.63 -7,087.06 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.34 -0.29 -0.17 -0.12 -0.07 -0.05 0.00 -
EPS Diluted -0.34 -0.29 -0.17 -0.12 -0.07 -0.05 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.